Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
- Immunohistochemistry [2]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1098105 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Polo-Like Kinase 1 (PLK1) (AA 331-508) antibody
- Antibody type
- Monoclonal
- Description
- Purified
- Reactivity
- Human, Mouse
- Host
- Mouse
- Epitope
- AA 331-508
- Isotype
- IgG
- Antibody clone number
- 3C11
- Vial size
- 100 μg
- Storage
- 4°C, -20°C for long term storage
Submitted references Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
Plk1 is negatively regulated by RNF8.
Intermedilysin induces EGR-1 expression through calcineurin/NFAT pathway in human cholangiocellular carcinoma cells.
Lin YC, Sun SH, Wang FF
Cellular signalling 2011 Nov;23(11):1816-23
Cellular signalling 2011 Nov;23(11):1816-23
Plk1 is negatively regulated by RNF8.
Yoshioka T, Kimura M, Saio M, Era S, Okano Y
Biochemical and biophysical research communications 2011 Jun 24;410(1):57-61
Biochemical and biophysical research communications 2011 Jun 24;410(1):57-61
Intermedilysin induces EGR-1 expression through calcineurin/NFAT pathway in human cholangiocellular carcinoma cells.
Susilowati H, Okamura H, Hirota K, Shono M, Yoshida K, Murakami K, Tabata A, Nagamune H, Haneji T, Miyake Y
Biochemical and biophysical research communications 2011 Jan 7;404(1):57-61
Biochemical and biophysical research communications 2011 Jan 7;404(1):57-61
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS